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Combined incubation of Cadmium,
docosahexaenoic and eicosapentaenoic
acid results in increased uptake of
cadmium and elevated docosapentaenoic
acid content in Hepatocytes in vitro
Pavla Linhartova* and Sabine Sampels
Abstract
Background: Human hepatocellular cells Hep G2 were used to mimic and investigate the effect of the intake of
cadmium (Cd2+) contaminated fish on cytotoxicity, fatty acid (FA) and phospholipid class composition.
Methods: Cells were incubated with a combination of Cd2+ and eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) fish specific FA.
Results: We measured a significant increased proportion of EPA and DHA in the treated cells compared to the control
line confirming the uptake. While doses of 25 μM DHA showed to be toxic to the cells, repeated short term incubations
(2 h) at lower doses resulted in an increased uptake of DHA. The resarzurin assay, evaluating cell viability, showed a
significant decrease in cell viability between Cd2+ incubation time and, further, the pre-incubation with BSA-FA complex
resulted in significantly increased cell viability. On the metabolic level, increased concentrations of EPA and DHA resulted
in an increased proportion of docosapentaenoic acid (DPA) which indicated an increased metabolism. Also 24-h
combined incubations of 5 μM Cd2+ and EPA and DHA showed a significant increase DPA in the total lipid fraction of the
cells. In addition, incubation with 5 μM Cd2+ for 24 h also decreased the total cardiolipin (CL) fraction from the identified
phospholipids.
Conclusions: We confirmed that the applied FA were taken up by the cells. A combination of EPA, DHA and Cd2+
influenced lysosomal integrity, cell viability and lipid metabolism in the cells. The most important finding is that DHA
and EPA reduced the detrimental effect of Cd2+ on cell viability. The exact effects and kinetics behind our observations
still need further evaluation.
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Background
Balancing risks and benefits of fish consumption is an
intensively discussed public health topic [1–3]. The
health benefits from eating fish, partly attributable to
omega-3 polyunsaturated fatty acids (n-3 PUFA), are
well documented both for prenatal development and
adult cardiovascular conditions [4, 5]. Due to their lipophi-
licity, fish take up and bioaccumulate heavy metals via feed
and from the water, which in turn passes up the food chain
into the human diet [6]. There have been no studies on the
combined effects of FA and Cd2+ on cell cytotoxicity.
Cd2+ is an environmental pollutant which is taken up
with drinking water and food, including seafood and fish.
The TDI (daily tolerable intake) for Cd2+ was calculated
according to the guidelines suggested by the Institute of
Standard and Industrial Research of Iran (ISIRI). Based on
ISIRI, the tolerable daily intake for Cd2+ is 1 μg/day kg of
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bw (body weight), [7]. Inorganic Cd2+ is a human carcino-
gen [8] and is classified as cancerogenic compound by the
International Agency for Research on Cancer (IARC) [9].
Long-term exposure to low concentrations of Cd2+ result
in accumulation in the liver and the kidneys (kidney
cortex) where 30–60 % of ingested Cd2+ is deposited
[10]. Cd2+ compounds have toxic effects on the
kidney and are assumed to be neurotoxic. These ef-
fects could be due to oxidative stress, but also by
different mechanisms that affect the cell membrane
composition [11, 12]. Cd2+ acts as a catalyst during
the formation of reactive oxygen species (ROS).
The long chain n-3 PUFA EPA and DHA have many
metabolic functions in animals and humans. Mammals
lack the Δ 15 desaturase that is essential for insertion of
double bonds at n-3 and hence cannot synthesize the
parent FA 18:3 n-3 [13]. In addition it has not been
established whether mammals are able to elongate and
desaturate 18:3 n-3 towards 20:5 n-3, 22:5 n-3 and 22:6
n-3 in significant amounts [14–16]. Therefore, these FA
are regarded as essential for humans and they need to
be included in the diet. They are vital nutrients and
precursors of several metabolites, which are potent lipid
mediators, known to be beneficial in the prevention and
treatment of several diseases [17]. Fish are an important
source of these FA and hence the consumption of fish
(200 g portion) at least twice a week is recommended by
several health organizations including FAO/WHO [18].
In the same report, the negative effects of eating con-
taminated fish are out weight against the benefits of the
FA. However, it is unclear which exact mechanisms are
affected by cadmium intake in relation to lipid metabol-
ism and oxidative stress when it is simultaneously taken
up with the long chain n-3 FA from fish.
The aim of the present study was therefore to evaluate
the combined effects of the nutritional essential FA EPA
and DHA from fish and Cd2+. Our hypothesis took two
aspects into account: Cd2+ is known to create oxidative
stress in the cells, so one of the toxic effects could be
the oxidation of important membrane or organelle FA
or phospholipids, subsequently leading to cellular dys-
function or apoptosis. If contaminated fish are ingested,
the long chain n-3 FA from the fish, which are the FA
most easily oxidized, could prevent or decrease the
impact of Cd2+ either by replacing the oxidized FA, or
conversely by increasing the oxidative stress and thereby
worsen the effects of the Cd2+. Hepatocytes were
selected for the investigation because the liver is a target
organ for Cd2+. A combination of DHA/EPA as 2/1
reflects the typical ratio in many fatty fish, common carp
(Cyprinus carpio) for example, which is traditionally
consumed in Czech Republic. In order to mimic the
uptake of contaminated fish, we investigated the meta-
bolic effects of cadmium (Cd2+) on the cell line Hep G2
in combination with the long chain n-3 PUFA, eicosa-
pentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic
acid (DHA; 22:6 n-3) which are typical for fish [19, 20].
Methods
Caution
Inorganic cadmium chloride (CdCl2, Cd
2+) is classified as
a human carcinogen [21] it is hazardous, or potentially
hazardous and should be handled with care.
Chemicals
Eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) supplied from Biochrom and Sigma-Aldrich (Berlin,
Germany), were diluted in extra pure 98 % ethanol and
bovine serum albumin (BSA) before transfer experiments.
Hydrogen peroxide solution (30 %, Suprapurs) and nitric
acid (65 %, Suprapur) were products of Merck (Darmstadt,
Germany). Cadmium chloride was obtained from Aldrich,
Germany. All other pro-analysis chemicals were obtained
from Sigma-Aldrich (Steinheim, Germany) and Merck
(Darmstadt, Germany). Trypsin, penicillin and strepto-
mycin solutions were products of Sigma (Deisenhofen,
Germany). Moreover, the culture dishes and the culture
medium (MEM) for Hep G2 cells were obtained from
Biochrom (Berlin, Germany).
Cell culture
Human hepatocellular cells (Hep G2, ATCC, No.
HB-8065) were purchased from the American Type
Culture Collection (ATCC, Manassas, V C, USA).
Hep G2 cells were grown as a monolayer in culture
dishes in Minimum Essential Medium Eagle (MEM)
supplemented with FCS (10 %, v/v), non-essential
amino acids (1 %, v/v), glutamine (2 mM), penicillin
(100 U/mL) and streptomycin (100 μg/mL). The Hep
G2 cultures were incubated at 37 °C with 5 % CO2
in air with 100 % humidity. Cells were passaged
every 3 days. The amount of 1.5 million cells were
seeded on 10 cm (in diameter) sterile Petri dishes in
10 mL of sterile culture medium (MEM). Suspen-
sions of Hep G2 cells were produced from confluent
cultures using trypsin/EDTA solution. Before the
transfer experiments, cells were three times sub-cultured
to achieve a stable phenotype. For the transfer experi-
ments, cells were seeded at a density of 66.7 cells per μL
for 96 well plates and 1.5 Mio (million) per normal petri
dishes (10 cm in diameter). Seeded Hep G2 were cultured
for 24 h and 37 °C and subsequently prepared for pre-
incubations and post-incubations with FA and Cd2+. Hep
G2 cells where used from passage Nr. 20 at least 3–4
weeks (till passage Nr. 35). Hep G2 cells can be used from
the third passage to Nr. 130. Hep G2 cells were incubated
with Cd2+ only, with Cd2+ and with BSA solved in PBS in
order to evaluate if the BSA alone would have any effects
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and finally with Cd2+ and the FA (EPA +DHA) as a BSA-
FA complex.
EPA and DHA pre-incubations
Before incubation fresh stock solutions of FA diluted in
extra pure 98 % EtOH were defrosted. The BSA-FA
complex was prepared as follows: BSA was dissolved in
PBS (phosphate buffer saline). EPA and DHA were
dissolved in extra pure EtOH to a final volume of
50 μL. Then 20 μL of EPA and DHA solutions were
added to 1 ml of a mixture of 0.1 M NaOH and BSA
solution (1/5; v/v) each. The two solutions of FA were
then combined and the pH was adjusted to 7.1 using
0.1 M HCl. After testing concentrations from 1–50 μM
EPA and from 2–100 μM DHA, we chose concentra-
tions for pre-incubations of liver human cells with
5 μM EPA+ 10 μM DHA for 2–48 h without changing
the cell culture medium (MEM).
Cd2+ post-incubations
Fresh stock solutions of Cd2+ diluted in distilled sterile
water (ddH2O) were prepared before the transfer experi-
ments. Hep G2 liver cells were post-incubated for 24 h
or 48 h with Cd2+ stock solution with changing the cell
culture medium (MEM). The range of Cd2+ concentra-
tions were used from min. 0.25 μM to max. 20 μM.
Cytotoxicity and lysosomal integrity
The neutral red assay was used to assess the impact
of the heavy metal on lysosomal integrity [22] using a
plate reader (Invinite 200Pro, Tecan Group Ltd.,
Mannedorf, Switzerland). The levels of IC50 and IC70
were measured so as to indicate the percentage of
control in the parameter of lysosomal integrity.
Cytotoxicity and cellular viability
Cellular viability, was measured with the resarzurin
uptake assay [23] using a plate reader (Invinite 200Pro,
Tecan Group Ltd., Mannedorf, Switzerland). The levels
of IC50 and IC70 were measured so as to indicate
percentage of control in the parameter of cell viability.
Pelleting of Hep G2 cells
Cells were seeded in number of 1.5 million cells per
Petri dish to 10 mL MEM sterile culture medium.
Seeded Hep G2 were cultured and treated with FA as
a BSA-FA complex and Cd2+ for the appropriate
times as described above. Subsequently cells were
pelleted by trypsinising and centrifuging several times
in PBS/FKS solution and frozen on −80 °C.
Fatty acid composition and phospholipid classes
The pelleted cells were re-suspended in buffer and the
total lipids were extracted from cells according to Hara
and Radin [24]. From these extracts, the composition of
major lipid classes as well as phospholipid classes were
evaluated via automated high performance thin layer
chromatography (HPTLC), [24, 25]. For analyses of FA
composition, methylation of total lipids was performed
by using a combination of NaOH and BF3 according to
Appelqvist [26]. FA composition was then analyzed by
GC on a BPX-70 50 m fused silica capillary column (id.
0.22 mm, 0.25 μm film thickness, SGE, USA) as de-
scribed Sampels et al. [27]. Identification of FA and
phospholipid classes was done by commercially available
external standards (Nu-Check Prep, Inc. Elysian USA;
Avanti Polar Lipids, Inc., Alabama, USA) quantification
of the FA was done by internal standard (C 21:0, Nu-
Check Prep, Inc. Elysian USA). Total fat and phospho-
lipids and FA as % of total identified per million cells in
μg were evaluated.
Determination of cadmium uptake
The content of cadmium chloride was analyzed via
ICP-MS as described earlier [28]. Quantification was
performed with authentic standards. Cd2+ concentra-
tion in μM in pelleted cells was analyzed.
Statistical analysis
All analyses were conducted in triplicate or quadruplicate.
Normality and homogeneity of dispersions of studied values
and comparisons were made by analysis of variance (two
factorial ANOVA; factors: Cd2+ and FA) with subsequent
post hoc Tukey’s honest significant difference (HSD) test.
The values were expressed as means ± SD (n = 3). All ana-
lyses were performed at a significance level of p < 0.05 using
STATISTICA 9.0 for Windows.
Results
FA concentrations suitable for incubation trials
In order to establish suitable incubation concentrations
of FA, we first incubated the cells with the individual FA
ranging for EPA from 1 μM to 50 μM (Fig. 1a) and for
DHA from 2 μM to 100 μM (Fig. 1b), respectively. For
EPA, the highest 50 μM concentration was above toxic
effects for the cells (Fig. 1a). Neither the level of IC50,
nor level of the IC70 was reached. No significant change
on cell growth measured by lysosomal integrity was
found for this FA. For DHA, significant changes were
found only between control line (Hep G2) and cells
treated with 25 μM DHA and higher DHA concentra-
tions showed significant toxic effects on the cells
(Fig. 1b). A significantly negative effect of DHA on Hep
G2 cell growth was observed after in vitro for 24 h at
concentrations 50 μM DHA (IC70) and the IC50 was
reached at the level of 76 μM DHA (Fig. 1b). Further-
more, the cells showed only 29.3 % vitality at a level of
100 μM DHA (Fig 1b). In a second step we evaluated
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the effects of the incubation with a combination of
EPA and DHA. The combination of 40 μM EPA+
75 μM DHA resulted in a cell viability significantly
below 50 % (18.9 % viable cells), while the combin-
ation of 10 μM EPA+ 20 μM DHA, was above the
level IC70 (85.3 % vital cells) (Fig. 2), but was signifi-
cantly lower compared to the control cells without
added FA. As the level of DHA was still too high,
we decreased the concentration to a combination of
5 μM EPA+ 10 μM DHA (Fig. 2). With these
concentrations a cell viability of 96.9 % (EPA5 +
DHA10) was reached. No cytotoxic effects of FA on
cell growth in this combination with control line
were found.
Cell viability
The resarzurin assay, evaluating cell viability, showed a
significant correlation between Cd2+ incubation time and
decreasing cell viability; an IC50 value of 6.6 μM and IC70
of 4 μM were measured after 24 h (Fig. 3a: Hep G2) and
an IC50 value of 4.1 μM and IC70 of 3 μM after 48 h
(Fig. 3b: Hep G2). Cell viability was significantly different
in comparison to the control cells at 5 μM Cd2+ for both
incubation times (Fig. 3ab).
Fig. 1 Lysosomal integrity after in vitro pre-incubations of Hep G2 for 24 h with EPA (a) at nominal concentrations of 10, 25, 40 and 50 μM and
DHA (b) at nominal concentrations of 25, 50, 75 and 100 μM compared to control cells. Data are presented as means ± SD, n = 3. Different letters
denote significant difference between treatments (ANOVA, p < 0.05)
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Pre-incubation with the BSA-FA complex resulted
in significantly increased cell viability at concentra-
tions starting at 5.5 μM Cd2+ (IC70) for FA group in
comparison with only 4 μM Cd2+ for control-Hep G2
(IC70) and only 3.6 μM Cd
2+ (IC70: Hep G2 + BSA),
after 24 h post-incubations with Cd2+ (Fig. 3a). No ef-
fects of BSA dissolved in PBS alone incubated with
the cells (Hep G2 + BSA) were found compare to con-
trol (Hep G2), which demonstrated that the BSA can
be used without affecting cell growth (Fig. 3ab).
Hep G2 lipid composition: phospholipids and fatty acids
Table 1 shows the contents of the long chain omega3-
FA (EPA, DPA, DHA) in the cells with or without incu-
bation of the FA for 24 h. A significant increase in the
cells of both EPA and DHA was shown after the incuba-
tion (Fig. 4a and b). We demonstrated that after only
two hours the maximum uptake of FA (Fig. 4b) was
reached and there were no significant difference between
2, 24 or 48 h of FA incubation per million cells in Fig. 4a.
Further we showed that repeated incubations were more
effective. This was probably due to the totally increased
substrate. After three replicated 2-h incubations with
EPA or DHA (total 6 h of FA incubation of the cells with
changing the medium every 2 h) proportions of FA in
the cells were significantly increased compared to all
other treatments and without toxic effects. When
expressed as percentage of total fat, the increase of DPA
was also significant after the incubation with FA; this
suggests a synthesis from EPA toward DHA (Fig. 4b).
When expressed as μg of fat per million (Mio.) cells, the
increase of DPA was significant for only the 3 × 2-h incu-
bation, which supports the hypothesis that an increased
proportion of EPA will lead to an increased metabolism
towards DHA (Fig. 4a). The level of EPA reached 1.31 μg
per Mio. cells and the DHA level was almost eight times
higher (2.33 μg per Mio. cells) compared to untreated cells
(Fig. 4a). Moreover, EPA increased to 9.5 % and DPA to
3.3 % and the DHA level was almost three times higher
(15.4 % of total identified FA than the untreated cells
(Fig. 4b). In the control line, without FA incubation, both
EPA and DPA showed levels of 0.6 % and DHA 2.7 % of
total identified FA (Fig. 4b). Even though uptake had
reached the maximum after 2 h, for practical reasons we
decided to use 24-h pre-incubations for the subsequent
FA and Cd2+ experiments.
Incubation with Cd2+ did not influence the content of
EPA or DHA, (Table 1). However the subsequent incu-
bation of the cells with the FA and 5 μM Cd2+ resulted
in a significant increase of DPA.
There were no significant differences in phospholipid
composition of the cells related to the pre-incubation
with FA. Therefore, the data were combined to facilitate
statistical evaluation. Figure 5 shows the phospholipid
class composition in the Hep G2 after the various incu-
bations. The phospholipids cardiolipin (CL) decreased
significantly after incubation with 5 μM Cd2+ for 24 h.
At this level of cadmium, only 12.1 % of CL were
detected in cells compared to 14.9 % at 1 μM Cd2+ and
15.4 % without any cadmium treatment (Fig. 5). The
decrease of CL between 1 μM and 5 μM incubations
was significant (p < 0.05).
Uptake of Cd in relationship with FA
Figure 6 shows the result from Cd uptake, which was
verified by ICP-MS. Three different concentrations of
Fig. 2 Lysosomal integrity after in vitro pre-incubations of Hep G2 for 24 h with combined EPA+ DHA. Nominal concentrations of EPA5 + DHA10 µM,
EPA10 + DHA20 μM and EPA40 +DHA75 μM compare to control cell line (Hep G2). Data are presented as means ± SD, n= 3. Superscript letters indicate
significant differences between treatments (ANOVA, p < 0.05)
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Fig. 3 Cell viability after in vitro pre-incubations of Hep G2 for 24 h with 5 μM EPA+ 10 μM DHA dissolved as BSA complex and 24 h (a) and
48 h (b) post-incubations with Cd2+ at nominal concentrations of 0.25, 0.5, 1, 2.5, 5, 10, 20 μM with changing culture (MEM) medium. Data are
presented as means ± SD, n = 3. Different letters denote significant differences between treatments (two factorial, ANOVA, (FA, Cd2+), p < 0.05)
Linhartova and Sampels Lipids in Health and Disease  (2015) 14:156 Page 6 of 11
Cd (1, 2.5 and 5 μM) were tested. One-half of pelleted
cells was pre-incubated with FA for 24 h and all groups
where then post-incubated with Cd2+ for the same time.
The group incubated with the highest 5 μM Cd2+ and
FA (5 μM EPA + 10 μM DHA), had a significantly higher
uptake of cadmium chloride (457.6 365.8 μM), compared
to the group not treated with FA (365.8 μM μM Cd2+).
Discussion
In the present study we used a combination of EPA +
DHA in a ratio 1:2 which is a proportion of FA typical
for fatty fish such as common carp (Cyprinus carpio);
carps are available on the local market year round [29].
Despite that fact that 60 μM DHA has been considered
as physiological relevant [30], we found that the IC70
level had been already reached at 50 μM DHA. Our
findings are in agreement with earlier results that DHA
has cytotoxic effects on cancerogenic cells; similar toxic
effects of DHA on cancerogenic neuroblastoma cells but
not on non-transformed nervous tissue have been re-
ported by Lindskog et al. [31]. These authors concluded
that DHA counteracted cancer by causing apoptosis in
the cancer cells. Juaudzus et al. [32] also showed that
relatively high doses of DHA did not affect healthy cells.
In the cell lines MIA PaCa-2, PANC-1 and CFPAC (human
pancreatic cell lines), EPA was also shown to have an in-
hibitory effect of cell growth (IC50 2.5-5 μM), [33]. In con-
trast, we found cytotoxic effects of DHA but not of EPA at
concentrations of 50 μM. The mechanisms by which DHA
acts differentially on cancerogenic versus normal healthy
cells are still under discussion. In their review [34] describes
the main mechanism to oxidative stress created by oxida-
tion compounds derived from DHA. Due to their increased
metabolism, cancer cells have increased natural levels of
ROS and additional ROS can then not be counteracted as
well as in healthy cells where the antioxidant mechanisms
are still intact.
According to our results in the present setting, 5 μM
EPA+ 10 μM DHA were the most suitable incubation
concentrations for hepatocellular human liver cells (Hep
G2; ATCC). We showed that the effect of EPA and DHA
on the cells seems to be different, which should be
evaluated further.
We showed that the incubated FA was taken up by the
cells (Table 1), however, we found an increase of those FA
only in the total lipid fraction (Table 1) and not in the
subcellular lipid fractions (data not shown), indicating that
an incubation time up to 48 h is probably too short for
the FA to be incorporated into the cell structure.
When evaluating the incubation times, the maximum
uptake already had been reached after only 2 h incuba-
tion with FA. After this, the proportion of the used FA
did not significantly further. In contrast, Obermeier et al.
[35] showed that the maximum levels of incorporation of
AA, EPA, and DHA into U937 cell (human leukemic
monocyte lymphoma cell line) was reached after 8 h. This
finding suggests that different cell types might have differ-
ent time optima for the uptake. Consequently, we decided
to use 24-h incubation times for improved practical hand-
ling and to ensure a good repeatability.
In line with our results, Fujiyamafujiwara et al. [36]
also found that incubation of Hep G2 cells with EPA
resulted in a dose-dependent incorporation of EPA
and a metabolism towards DPA but not DHA. The
authors also found an increase of DHA, but a lower
dose dependency, plus an increased amount of DPA in
the cells after incubation with DHA, suggesting that
DHA was ß-oxidized into DPA. These findings sup-
port our hypothesises that an increased proportion of
substrate, in our case EPA, results in increased synthe-
sis of the longer chain FA as well as a higher ß-oxida-
tion of increased amounts of DHA into DPA.
In addition, we showed that repeated incubations are
more effective. This is probably due to the totally increased
Table 1 Fatty acid content in Hep G2 cells
μg FA per Mio cells BSA-control no FA BSA-FA (24 h) BSA-control no FA Cd5 (24 h) BSA-FA (24 h) Cd5 (24 h)
C20:5n-3 0.09 ± 0a 0.37 ± 0.09b 0.14 ± 0.05a 0.59 ± 0.14b
C22:5 n-3 0.10 ± 0.01a 0.16 ± 0.03ab 0.17 ± 0.07ab 0.31 ± 0.06b
C22:6n-3 0.40 ± 0.06a 0.84 ± 0.08b 0.57 ± 0.22a 1.23 ± 0.19b
SFA 5.61 ± 0.98 5.47 ± 0.66 7.24 ± 3.20 8.38 ± 2.19
MUFA 8.19 + 0.98a 6.02 ± 0.33b 8.65 ± 2.88ab 7.48 ± 1.30b
PUFA 2,00 ± 0.29a 2.60 ± 0.28b 2.84 + 1.08ab 4.01 ± 0.44b
n-3 0.59 ± 0.07a 1.38 ± 0.10b 0.88 ± 0.34a 2.13 ± 0.23b
n-6 1.36 ± 0.26ab 1,20 ± 0,19b 1.94 ± 0.76a 1.81 ± 0.30ab
n-6/n-3 2.28 ± 0.18a 0.87 ± 0.08b 2.21 ± 0.02a 0.85 ± 0.08b
FA content (% of total identified) in Hep G2 cells incubated with or without FA (24 h) and subsequently with or without 5 μM Cd2+ for 24 h. ‘No FA’ means cells were
only incubated with BSA as control. Data are presented as means ± SD, n = 3. Different letters denote significant differences between treatments (two factorial ANOVA,
(FA, Cd2+), p < 0.05)
Abbreviations: PC L a-Phosphatidylcholine, CL Cardiolipin, PA L-a-Phosphatidic acid, and EA Phosphatidylethanolamine
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Fig. 4 (See legend on next page.)
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substrate. In this way it seems to be possible to load the
cells with greater amounts of EPA and DHA without the
toxic effects caused by higher concentrated doses. This
finding could be useful in future studies of the effects of
elevated PUFA levels. On a metabolic level, the increased
substrate also seems to result in a higher metabolism from
EPA towards DPA and possibly DHA.
One of our hypotheses was that Cd2+ could cause a
change in the cell lipid composition resulting in dys-
function and finally apoptosis. The results from the
resazurin assay, with a significant correlation between
Cd2+ incubation time and decreasing cell viability con-
curred with this, as the resarzurin method is based on
the fact that normal viable and healthy cells reduce the
blue resazurin to the pink resorfin. It is known that
resazurin is effectively reduced in the mitochondria,
making it useful also to assess mitochondrial metabolic
activity. Hence we think that Cd2+ affects the mito-
chondrial functions. A reason for this could be oxida-
tion of essential membrane lipids. An indication for
this is that the highest used concentration of Cd2+ re-
sulted in also decreased levels of cardiolipin (CL) in our
study. CL is exclusively localized in the inner mito-
chondrial membrane and important for mitochondrial
membrane functionality [37]. CL is especially sensitive
to oxidation due to the high content including DHA
[34]. Increased oxidation and subsequent decrease of
CL has been connected to apoptosis [34] which is also
inferred by our study.
In conclusion, our results, showed that a decrease in
the proportion of CL together with a decreased cell
viability, indicating that Cd2+ has an effect on cellular
lipid composition and mitochondrial function.
Interestingly, the co-incubation of FA and Cd2+ resulted
in a significantly higher uptake of Cd2+ at the highest con-
centrations of Cd2+ (5 μM), while the uptake seemed to
reach a maximum level at 2.5 μM (Fig 6). This finding is
in contrast to a study by Nostbakken et al., [38] evaluating
the effect of EPA and DHA on methyl mercury (MeHg)
uptake. In that study DHA decreased the uptake of MeHg
in HEK293. In line with our results, DHA increased the
uptake of the heavy metal and MeHg induced apoptosis in
ASK. However, in the same study, EPA had an opposing
effect and decreased the uptake of MeHg. Since we used a
combination of these FA in our study, this could also
mean that we had mixed increasing and decreasing effects
on the uptake of Cd2+. However, this hypothesis needs
further evaluation.
Another interessting result from our study was that
the combined incubation of the FA and Cd2+ at the
(See figure on previous page.)
Fig. 4 Content of EPA, DPAn-3, DHA and total amount of FA after in vitro incubations of Hep G2 for 2, 3x2, 24 and 48 h with 5 μM EPA+ 10 μM
DHA as BSA complex and different subsequent time of cell growth (30, 48 and 96 h), presented as μg of FA per Mio. cells (a) and total identified
FA (%) content (b). ‘No FA’ means cells were only incubated with BSA as control. Data are presented as means ± SD, n = 3. Different letters denote
significant differences of the respective FA between incubation times (ANOVA, p < 0.05)
Fig. 5 Phospholipid class composition presented as percentage of total identified (means ± SD, n = 3) after in vitro pre-incubations of Hep G2 for
24 h with 5 μM EPA+ 10 μM DHA dissolved as BSA complex and 24 h post-incubations with/without Cd2+ at nominal concentrations of 1 and
5 μM with changing culture (MEM) medium. Data are presented as means ± SD, n = 3. Different letters denote significant differences between
treatments (two factorial ANOVA, (FA, Cd2+), p < 0.05)
Linhartova and Sampels Lipids in Health and Disease  (2015) 14:156 Page 9 of 11
highest level increased the proportion od DPA in the
cells. This indicates either an upregulated metabolism
from EPA towards the longer chain products or an
increased β-oxidation from DHA due to energy needs of
the cells or oxidative stress. We hypothecize that Cd2+
has an enhancing effect on these processes. Therefore,
the next step should be to evaluate various levels of
oxidation and antioxidant response on the cells as well
as the protein expression of the related elongases.
Conclusion
The findings of the present study showed that the
applied FA were taken up by the cells and that sub-
sequent incubation with Cd2+ did not decrease the
contents of EPA and DHA. However, as a possible
adverse effect, the combined incubation of FA and
Cd2+ resulted in a significantly increased uptake of
Cd2+ at the highest used levels. The possible toxic
effects of this findings in vivo should be evaluated.
It should be highlighted that both FA (EPA and
DHA) reduced the detrimental effect of Cd2+ on cell
viability, which is the most relevant finding of present
study with potentially important implications regard-
ing fish consumption.
Further, the combined incubation of EPA and
DHA and Cd2+ increased the levels of DPA in the
total lipid content of the cells, which could either be
a sign of increased metabolism from EPA to DPA or
increased ß-oxidation from DHA to DPA induced by
the cadmium. We also found that incubation with
Cd2+ decreased CL, an essential phospholipid class
in the mitochondria, indicating that part of the toxic
effects of cadmium is related to mitochondria dys-
function. However, the reason for the increased DPA
values needs to be investigated as well as the general
oxidative stress parameters, which will be the subject
of our further work.
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